Europe Anxiety Disorders And Depression Treatment Market Size & Outlook

The anxiety disorders and depression treatment market in Europe is expected to reach a projected revenue of US$ 4,606.4 million by 2030. A compound annual growth rate of 3.4% is expected of Europe anxiety disorders and depression treatment market from 2024 to 2030.
Revenue, 2023 (US$M)
$3,644.1
Forecast, 2030 (US$M)
$4,606.4
CAGR, 2024 - 2030
3.4%
Report Coverage
Europe

Europe anxiety disorders and depression treatment market highlights

  • The Europe anxiety disorders and depression treatment market generated a revenue of USD 3,644.1 million in 2023.
  • The market is expected to grow at a CAGR of 3.4% from 2024 to 2030.
  • In terms of segment, antidepressants was the largest revenue generating drug in 2023.
  • Antidepressants is the most lucrative drug segment registering the fastest growth during the forecast period.


Europe data book summary

Market revenue in 2023USD 3,644.1 million
Market revenue in 2030USD 4,606.4 million
Growth rate3.4% (CAGR from 2023 to 2030)
Largest segmentAntidepressants
Fastest growing segmentAntidepressants
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAntidepressants


Other key industry trends

  • In terms of revenue, Europe region accounted for 29.3% of the global anxiety disorders and depression treatment market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,991.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Anxiety Disorders And Depression Treatment Market Scope

Anxiety disorders and depression treatment market segmentation & scope
Antidepressants
Anxiolytics
Anticonvulsants
Noradrenergic Agents
Atypical Antipsychotics
Indication
Depression
Anxiety
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait

Anxiety Disorders And Depression Treatment Market Companies

Name Profile # Employees HQ Website

Europe anxiety disorders and depression treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anxiety disorders and depression treatment market will help companies and investors design strategic landscapes.


Antidepressants was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe anxiety disorders and depression treatment market based on antidepressants covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe anxiety disorders and depression treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe anxiety disorders and depression treatment market databook

  • Our clientele includes a mix of anxiety disorders and depression treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe anxiety disorders and depression treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Europe anxiety disorders and depression treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more